usfda

 

Dr Reddy's gets temporary restraining order on sale of Suboxone

Jun 16 2018

Dr Reddy's Laboratories said that a US District Court has issued a temporary restraining order on the sale and commercialisation of its generic Buprenorphine and Naloxone sublingual film in US.

Dr Reddy's Lab shares surge 5% on USFDA nod for opioid drugs

Jun 15 2018

At NSE, shares of the company went up by 4.80 per cent to Rs 2,378.50.

Alembic Pharma shares up over 3 pc on USFDA nod

Jun 14 2018

Shares of Alembic Pharmaceuticals today rose by over 3 per cent after the company received approval from the US health regulator for its Doxycycline Hyclate capsules.

Alembic Pharma gets USFDA nod for its antibiotic capsules

Jun 14 2018

Alembic Pharmaceuticals said it has received approval from the US health regulator for its Doxycycline Hyclate capsules used for treatment of wide variety of bacterial infections.

Lupin gets USFDA approval for generic contraceptive drug

Jun 14 2018

Lupin said it has received approval from the US health regulator to market Drospirenone, Ethinyl Estradiol, Levomefolate Calcium tablets, used to prevent pregnancy, in the American market.

Cipla gets USFDA nod for generic Isuprel injection

Jun 13 2018

Cipla said it has received approval from the US health regulator for Isoproterenol Hydrochloride injection, used in the treatment of cardiac problems, in the American market.

Lupin launches generic antibiotic inhalation solution in US

Jun 13 2018

Lupin said it has launched its antibiotic Tobramycin inhalation solution in the US market.

Sun Pharma shares gain 4%; m-cap rises by Rs 2,384 cr

Jun 13 2018

Shares of Sun Pharmaceutical Industries today gained nearly 4 per cent after the company received EIR from the US health regulator for its Halol facility in Gujarat.

Strides Shasun shares rise over 5% on USFDA approval for new drug

Jun 12 2018

Shares of Strides Shasun today rose by over 5% after the company's subsidiary Strides Pharma Global received final approval from the US health regulator for generic Oseltamivir Phosphate capsules.

Alembic Pharma shares soar 20% on USFDA nod for drug

Jun 11 2018

Shares of Alembic Pharmaceuticals today surged 20 percent after the company received the US health regulator's nod for Bupropion Hydrochloride tablets, used for treatment of major depressive disorder.

Indian Markets

 
  • SENSEX

    35,583.27 38.87   (-0.11 %)
  • NIFTY

    10,808.85 8.85   (-0.08 %)
sensex-box-shadowimg

Global Markets

 

Stocks In News

 

PNC INFRA

U.P. Govt cancels Purvanchal Expressway bids

Co's Rs 1,740 Cr bid for expressway section cancelled

U.P. Govt to re-invite bids for expressway project

PANACEA BIOTEC

Settles Abraxane patent dispute with Celgene Corp

Partner Apotex may sell generic of Abraxane in U.S.

IDEA

Telecom Department may clear Vodafone-Idea merger today

PTI REPORT

DR REDDYS

Dr. Reddys new drug hits legal hurdle

U.S. court issues restraint order following patent litigation over Suboxone

Company remains confident in its legal positions on this patent Court order does not include a prohibition on commercial manufacturing of the product

The court has scheduled an expedited hearing of the preliminary injunction for June 28 Ruling is expected soon thereafter

ICICI BANK

Board mulls reshuffle of top management

ICICI Prudential Life Chief Bakshi may be named ICICI bank interim
ET REPORT

twitter @BTVI